Distribution and antimicrobial susceptibility profile of extended-spectrum β-lactamase-producing Proteus mirabilis strains recently isolated in Japan
Authors:
- 1 February 2015
- journal article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 45 (2) , 113-118
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Regional outbreak of CTX-M-2 β-lactamase-producing Proteus mirabilis in JapanJournal of Medical Microbiology, 2012
- Emergence of Proteus mirabilis Harboring bla KPC-2 and qnrD in a Chinese HospitalAntimicrobial Agents and Chemotherapy, 2012
- Antimicrobial Resistance in Urinary Tract Pathogens in Canada from 2007 to 2009: CANWARD Surveillance StudyAntimicrobial Agents and Chemotherapy, 2011
- Rapidly spreading CTX-M-type β-lactamase-producing Proteus mirabilis in JapanInternational Journal of Antimicrobial Agents, 2010
- Emergence of Proteus mirabilis Isolates Producing TEM-52 Extended-Spectrum β-Lactamases in CroatiaChemotherapy, 2010
- Characterization and Sequence Analysis of Extended-Spectrum-β-Lactamase-Encoding Genes from Escherichia coli, Klebsiella pneumoniae , and Proteus mirabilis Isolates Collected during Tigecycline Phase 3 Clinical TrialsAntimicrobial Agents and Chemotherapy, 2009
- Detection of KPC-2 in a Clinical Isolate of Proteus mirabilis and First Reported Description of Carbapenemase Resistance Caused by a KPC β-Lactamase in P. mirabilisJournal of Clinical Microbiology, 2008
- Complicated Catheter-Associated Urinary Tract Infections Due toEscherichia coliandProteus mirabilisClinical Microbiology Reviews, 2008
- Nosocomial Outbreak of Infections by Proteus mirabilis That Produces Extended-Spectrum CTX-M-2 Type β-LactamaseJournal of Clinical Microbiology, 2003
- Classification, Identification, and Clinical Significance of Proteus, Providencia, and MorganellaClinical Microbiology Reviews, 2000